Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease
Open Access
- 23 June 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 729
Abstract
Essentially all neonates are exposed to infections, antibiotics, or vaccines early in their lives. This is especially true for those neonates born underweight or premature. In contrast to septic adults and children who are at an increased risk for subsequent infections, early life exposure to infection during the neonatal period is not associated with an increased risk of subsequent infection and may be paradoxically associated with reductions in late onset sepsis in the most premature. Perinatal inflammation is also associated with a decreased incidence of asthma and atopy later in life. Conversely, septic neonates are at increased risk of impaired long-term neurodevelopment. While the positive effects of antibiotics in the setting of infection are irrefutable, prolonged administration of broad-spectrum, empiric antibiotics in neonates without documented infection is associated with increased risk of late onset sepsis, necrotizing enterocolitis, or death. Vaccines provide a unique opportunity to prevent infection-associated disease; unfortunately, vaccinations have been largely unsuccessful when administered in the first month of life with the exception of vaccines against hepatitis B and tuberculosis. Future vaccines will require the use of novel adjuvants to overcome this challenge. This review describes the influence of infections, antibiotics, and vaccines during the first days of life, as well as the influence on future health and disease. We will also discuss potential immunomodulating therapies, which may serve to train the preterm immune system and reduce subsequent infectious burden without subjecting neonates to the risks accompanied by virulent pathogens.Keywords
Funding Information
- National Institute of General Medical Sciences (K08 GM106143, R01 GM097531, and P50 GM111152)
This publication has 92 references indexed in Scilit:
- The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult LeukocytesPLOS ONE, 2013
- Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit ModelScience Translational Medicine, 2012
- The Burden of Invasive Early-onset Neonatal Sepsis in the United States, 2005–2008The Pediatric Infectious Disease Journal, 2011
- Prolonged Initial Empirical Antibiotic Treatment is Associated with Adverse Outcomes in Premature InfantsThe Journal of Pediatrics, 2011
- Low-Dose Lipopolysaccharide Selectively Sensitizes Hypoxic Ischemia-Induced White Matter Injury in the Immature BrainPediatric Research, 2010
- Microbiologic and Histologic Characteristics of the Extremely Preterm Infant's Placenta Predict White Matter Damage and Later Cerebral Palsy. The ELGAN StudyPediatric Research, 2010
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvantJournal of Experimental Medicine, 2009
- Group B Streptococcus and Early-Onset Sepsis in the Era of Maternal ProphylaxisPediatric Clinics of North America, 2009
- Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonistsBlood, 2008
- Antibiotic Resistance Patterns in Invasive Group B Streptococcal IsolatesInfectious Diseases in Obstetrics and Gynecology, 2008